495 related articles for article (PubMed ID: 36498919)
21. Interstitial cystitis/bladder pain syndrome patient is associated with subsequent increased risks of outpatient visits and hospitalizations: A population-based study.
Hsieh KL; Chin HY; Lo TS; Long CY; Ho CH; Huang SK; Chuang YC; Wu MP
PLoS One; 2021; 16(9):e0256800. PubMed ID: 34492065
[TBL] [Abstract][Full Text] [Related]
22. ESSIC criteria for the diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC) and comparison with the NIDDK criteria.
Proaño A; Garde G; Garrido G; Mazza O
Arch Esp Urol; 2013 Mar; 66(2):206-14. PubMed ID: 23589598
[TBL] [Abstract][Full Text] [Related]
23. Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.
Kim A; Han JY; Ryu CM; Yu HY; Lee S; Kim Y; Jeong SU; Cho YM; Shin DM; Choo MS
Histopathology; 2017 Sep; 71(3):415-424. PubMed ID: 28394416
[TBL] [Abstract][Full Text] [Related]
24. Diffusion-Weighted Magnetic Resonance Imaging: A New Tool for the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.
Charlanes A; Boudghene F; Chesnel C; Ciofu C; Le Breton F; Jousse M; Amarenco G; Manceau P
Urol Int; 2019; 102(1):109-112. PubMed ID: 30428470
[TBL] [Abstract][Full Text] [Related]
25. Clinical guidelines for interstitial cystitis/bladder pain syndrome.
Homma Y; Akiyama Y; Tomoe H; Furuta A; Ueda T; Maeda D; Lin AT; Kuo HC; Lee MH; Oh SJ; Kim JC; Lee KS
Int J Urol; 2020 Jul; 27(7):578-589. PubMed ID: 32291805
[TBL] [Abstract][Full Text] [Related]
26. Anesthetic Bladder Capacity is a Clinical Biomarker for Interstitial Cystitis/Bladder Pain Syndrome Subtypes.
Plair A; Evans RJ; Langefeld CD; Matthews CA; Badlani G; Walker SJ
Urology; 2021 Dec; 158():74-80. PubMed ID: 34303757
[TBL] [Abstract][Full Text] [Related]
27. Do medication prescription patterns follow guidelines in a cohort of women with interstitial cystitis/bladder pain syndrome?
Tholemeier LN; Bresee C; De Hoedt AM; Barbour KE; Kim J; Freedland SJ; Anger JT
Neurourol Urodyn; 2022 Jun; 41(5):1121-1126. PubMed ID: 35391498
[TBL] [Abstract][Full Text] [Related]
28. Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome.
Whitmore KE; Fall M; Sengiku A; Tomoe H; Logadottir Y; Kim YH
Int J Urol; 2019 Jun; 26 Suppl 1():26-34. PubMed ID: 31144757
[TBL] [Abstract][Full Text] [Related]
29. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
30. [Diagnosis of interstitial cystitis: practice-orientated diagnostic work-up].
Foresti A; Schultz-Lampel D
Aktuelle Urol; 2021 Dec; 52(6):547-555. PubMed ID: 34734396
[TBL] [Abstract][Full Text] [Related]
31. Stem Cell Therapy for Interstitial Cystitis/Bladder Pain Syndrome.
Kim A; Shin DM; Choo MS
Curr Urol Rep; 2016 Jan; 17(1):1. PubMed ID: 26686192
[TBL] [Abstract][Full Text] [Related]
32. Multimodal Single-Cell Analyses Outline the Immune Microenvironment and Therapeutic Effectors of Interstitial Cystitis/Bladder Pain Syndrome.
Su F; Zhang W; Meng L; Zhang W; Liu X; Liu X; Chen M; Zhang Y; Xiao F
Adv Sci (Weinh); 2022 Jun; 9(18):e2106063. PubMed ID: 35470584
[TBL] [Abstract][Full Text] [Related]
33. Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report.
Fall M; Nordling J; Cervigni M; Dinis Oliveira P; Fariello J; Hanno P; Kåbjörn-Gustafsson C; Logadottir Y; Meijlink J; Mishra N; Moldwin R; Nasta L; Quaghebeur J; Ratner V; Sairanen J; Taneja R; Tomoe H; Ueda T; Wennevik G; Whitmore K; Wyndaele JJ; Zaitcev A
Scand J Urol; 2020 Apr; 54(2):91-98. PubMed ID: 32107957
[No Abstract] [Full Text] [Related]
34. Latest insights into the pathophysiology of bladder pain syndrome/interstitial cystitis.
Tornic J; Engeler D
Curr Opin Urol; 2024 Mar; 34(2):84-88. PubMed ID: 38117118
[TBL] [Abstract][Full Text] [Related]
35. The misdiagnosis of interstitial cystitis/bladder pain syndrome in a VA population.
Skove SL; Howard LE; Senechal J; De Hoedt A; Bresee C; Cunningham TJ; Barbour KE; Kim J; Freedland SJ; Anger JT
Neurourol Urodyn; 2019 Sep; 38(7):1966-1972. PubMed ID: 31302944
[TBL] [Abstract][Full Text] [Related]
36. Relevance of the Endoscopic Evaluation in the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis.
Morlacco A; Mancini M; Soligo M; Zattoni F; Calpista A; Vizzielli G; Patti R; Mandato FG; Barneschi AC; Zattoni F; Iafrate M; Dal Moro F;
Urology; 2020 Oct; 144():106-110. PubMed ID: 32619597
[TBL] [Abstract][Full Text] [Related]
37. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
[TBL] [Abstract][Full Text] [Related]
38. Methods and incentives for the early diagnosis of bladder pain syndrome/interstitial cystitis.
Fall M; Peeker R
Expert Opin Med Diagn; 2013 Jan; 7(1):17-24. PubMed ID: 23530841
[TBL] [Abstract][Full Text] [Related]
39. Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.
Akiyama Y; Luo Y; Hanno PM; Maeda D; Homma Y
Int J Urol; 2020 Jun; 27(6):491-503. PubMed ID: 32246572
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and therapeutic cystoscopy in bladder pain syndrome/interstitial cystitis: systematic review of literature and consensus on methodology.
Taneja R; Pandey S; Priyadarshi S; Goel A; Jain A; Sharma R; Purohit N; Bandukwalla V; Tanvir ; Ragavan M; Agrawal A; Shah A; Girn Z; Ajwani V; Mete U
Int Urogynecol J; 2023 Jun; 34(6):1165-1173. PubMed ID: 36708406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
